NEET Registry

The Inception Research Institute and The Prelude Network® are partnering in a patient registry designed to study the outcomes of non-euploid embryo transfers (NEETs).

Preimplantation Genetic Testing for Aneuploidy (PGT-A) is widely offered as an option for patients pursuing pregnancy through in vitro fertilization (IVF). Most often, embryos with normal chromosome results are selected for transfer, with well established outcomes. Transferring an embryo with a non-euploid result (i.e., mosaic, isolated segmental aneuploid or aneuploidy of whole chromosome(s)) may be considered for a variety of patient specific reasons. However, little information is available on the long-term outcomes of mosaic embryo transfer. Even less has been published on outcomes for other types of non-euploid results.

The NEET Registry aims to collect prenatal, neonatal and pediatric outcome information for embryos transferred with the various types of non-euploid PGT-A results to support providers and patients in their decision making regarding such transfers.

Sign Up
IVF Cycle

Key Participant Requirements

During the study, participants who are eligible will:

card
Attend scheduled clinic visits.
card
Have blood drawn to evaluate hormone levels.
card
Complete transvaginal ultrasounds designed to monitor changes to the ovaries, uterine lining, or pregnancy, if applicable.
card
Receive study medications to self-administer as instructed by the clinic staff.
Inception Fertility is the largest network of fertility centers in North America. Its family of brands is committed to helping aspiring parents build modern families while pursuing their fertility journeys on their own terms. Built by patients for patients, Inception seeks to set the highest bar for patient experience and outcomes through advanced reproductive science and technology.
©2025 Inception Fertility, Inc. All rights reserved.
>